SEC Filings

Filing date	Form	Description	View
05/04/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-007376.pdf 0001415889-23-007376.rtf 0001415889-23-007376.xls
05/04/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-007378.pdf 0001415889-23-007378.rtf 0001415889-23-007378.xls
05/04/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-007380.pdf 0001415889-23-007380.rtf 0001415889-23-007380.xls
05/04/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-007382.pdf 0001415889-23-007382.rtf 0001415889-23-007382.xls
05/04/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-007384.pdf 0001415889-23-007384.rtf 0001415889-23-007384.xls
05/03/23	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-055518.pdf 0001104659-23-055518.rtf 0001104659-23-055518.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
04/20/23	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001415889-23-006775.pdf 0001415889-23-006775.rtf 0001415889-23-006775.xls
04/18/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-006620.pdf 0001415889-23-006620.rtf 0001415889-23-006620.xls
04/17/23	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-045844.pdf 0001104659-23-045844.rtf 0001104659-23-045844.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
04/14/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-000113.pdf 0001950047-23-000113.rtf 0001950047-23-000113.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.